Patient & Visitor Alert: Because flu cases are on the rise, starting February 24, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities throughout Carolinas HealthCare System. Learn more.
A Multicenter Study for the Validation of ALS Biomarkers
The primary objective is to identify factors that contribute to the pathogenesis of amyotrophic lateral sclerosis (ALS). Development of disease biomarkers and diagnostic laboratory tests would facilitate earlier treatment intervention, help monitor treatment efficacy; and, ultimately, lead to the identification of targets that could be used in therapy development. Specific aim 2 is to assess how biomarkers discovered in aim 1 change with disease course. Blood samples will be collected longit
Who may be Eligible
Male and females over the age of 18 with a diagnosis of ALS.